Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer

Oncogene

Volumn 16, Issue 16, 1998, Pages 2159-2164

  Fujii, Hiroaki ^a,c   Biel, Margaret A ^a   Zhou, Weibo ^a   Weitzman, Sigmund A ^b   Baylin, Stephen B ^a   Gabrielson, Edward ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

Breast cancer; Chromosome 17; HIC 1; Methylation; Tumor suppressor gene

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; BREAST RECONSTRUCTION; CHROMOSOME 17P; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; EPITHELIUM CELL; GENE ACTIVITY; GENE EXPRESSION; GENE LOCATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0032559995     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201976     Document Type: Article

References (28)

1. Albagli O, Dhordain P, Deweindt C, Lecocq G and Leprince D. (1995). Cell Growth & Differ., 6, 1193-1198.
2. Andersen TI. Gaustad A, Farrants GW, Nesland JM, Tveit KM and Borresen A. (1992). Genes Chrom. Cancer, 4, 113-121.
3. Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J and Yu AL. (1997). Cancer Res., 57, 832-836.
4. Bieche I and Lidereau R. (1995). Genes Chrom. Cancer, 14, 227-251.
5. Cavenee WK. (1991). Cancer, 67, 2431-1435.
6. Chen Z, Brand NJ, Chen A, Chen SJ, Tong JH, Wang ZH, Waxman S and Zelent A. (1993). EMBO J., 12, 1161-1167.
7. Coles C, Thompson AM, Elder PA, Cohen BB, Mackenzie IM, Cranston G, Chetty U, Mackay J, Macdonald M, Nakamura Y, Hoyheim B and Steel CM. (1990). Lancet, 336, 761-763.
8. Cornelis RS, van Vleit M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Borresen AL, Cornelisse CJ and Devilee P. (1994). Cancer Res., 54, 4200-4206.
9. Cross SH and Bird AP. (1995). Curr. Opin. Genetics Dev., 5, 309-314.
10. Deng G, Chen L, Schott DR, Thor A, Bhargava V, Ljung B, Chew K and Smith HS. (1994). Cancer Res., 54, 499-505.
11. Fujii H, Szumel R, Marsh C, Zhou W and Gabrielson E. (1996a). Cancer Res., 56, 5260-5265.
12. Fujii H, Zhou W and Gabrielson E. (1996b) Genes Chrom. Cancer, 16, 35-39.
13. Greenblatt MS, Bennett WP, Hollstein M and Harris CC, (1994). Cancer Res., 54, 4855-4878.
14. Herman JG, Latif F, Weng Y, Lerman MI. Zbar B, Liu S, Samid D, Duan DS, Gnarra J, Linehan WM and Baylin SB. (1994). Proc. Natl. Acad. Sci. USA, 91, 9700-9704.
15. Herman JG, Civin CI, Issa JPJ, Collector MI. Sharkis SJ and Baylin SB. (1997). Cancer Res., 57, 837-841.
16. Makos M, Nelkin BD, Lerman MI. Latif F, Zbar B and Baylin SB. (1992). Proc. Natl. Acad. Sci. USA, 89, 1929-1933.
17. Makos M, Nelkin BD, Chazin VR, Cavenee WK, Brodeur GM and Baylin SB. (1993a). Cancer Res., 53, 2715-2718.
18. Makos M, Nelkin BD, Reiter RE, Gnarra JR, Brooks J, Isaacs W, Linehan M and Baylin SB. (1993b). Cancer Res., 53, 2719-2722.
19. Makos-Wales M, Biel MA, El Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ and Baylin SB. (1995). Nature Med., 1, 570-577.
20. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D. (1995). Nature Med., 1, 1-8.
21. Miki T, Kawamata N, Hirosawa S and Aoki N. (1994). Blood. 83, 26-32.
22. Morton RA, Bova GS, Wales MM, Baylin SB and Isaacs WB. (1996). J. Urol., 156, 512-516.
23. Phillips NJ, Zeigler MR and Deaven LL. (1996). Cancer Res., 102, 85-90.
24. Razin A and Cedzar H. (1994). Cell. 77, 473-476.
25. Riggs AD and Pfeifer GP. (1992). Trends Genet., 8, 169-174.
26. Sato T, Akiyama F, Sakamoto G, Kasumi F and Nakamura Y. (1991). Cancer Res., 51, 5794-5799.
27. Schultz DC, Vanderveer L, Berman DB. Hamilton TC, Wong AJ and Godwin AK. (1996). Cancer Res., 56, 1997-2002.
28. Stampfer MR. (1985). J. Tissue Culture Methods, 9, 107-115.